Sex Differences in the Hepatotropic Effects of Antiulcer Drugs and Placenta Cryoextract in an Experimental Rat Liver Injury Model

Keywords: cryopreserved placenta extract, peptic ulcer, hepatitis, liver cirrhosis, sexual dimorphism, comorbidity

Abstract


Background/Aim: Sex-related variances in drug metabolism provide a foundation for refining treatment protocols for prevalent conditions based on the patient's sex. Tailoring treatment strategies based on sex is particularly noteworthy among patients with comorbid illnesses due to the potential for drug interactions and the impact of concurrent diseases on clinical outcomes. Aim of thi study was to assess the hepatotropic effects of antiulcer drugs (esomeprazole, clarithromycin and metronidazole – E/C/M) and placenta cryoextract (CEP) within a simulated model of tetrachloromethane (CCl4)-induced hepatitis combined with underlying ethanol-induced liver cirrhosis (EILC), with a focus on the role of subjects' sex.

Methods: Using 112 male and female rats, the research explored the effects of different sex hormone levels. Chronic EILC was induced by administering a 50.0 % CCl4 oil solution (8 mL/kg) twice a week, combined with a 5.0 % ethanol solution, over 45 days. Total protein (TP) levels and alkaline phosphatase (AP) activity were measured spectrophotometrically.

Results: The research findings indicate that the onset of EILC and the administration of E/C/M resulted in a significantly greater 10.8 % (p = 0.03) reduction in TP levels among females compared to males, without altering hormonal status. Introducing CEP led to a noteworthy (p < 0.001) rise in TP levels, by 30.8 % in males and 33.9 % in females, in the context of EILC and E/C/M administration, while maintaining hormonal status.

Among male rats, the most elevated AP activity was observed with excess testosterone propionate administration (5.0 [5.0; 5.9] μmol/L), while the lowest level was recorded in rats after testectomy, measuring 3.8 [2.5; 4.7] μmol/L, exhibiting a significant 20.8 % decrease (p < 0.05) compared to male rats without hormonal status changes. In female rats, the study revealed that against the backdrop of EILC and E/C/M administration, the highest AP level was seen in ovariectomised females, reaching 5.8 [5.1; 6.2] μmol/L, reflecting a substantial 9.4 % increase compared to rats without hormonal status changes.

Conclusions: The administration of CEP under similar experimental conditions led to the recovery of the liver's protein-synthesising function in both male and female rats. When female sex hormones were introduced to sham-operated female rats, a significant 20.8 % greater reduction in AP levels was observed. Additionally, gonadectomy led to a more pronounced decrease in this enzyme's levels in male rats compared to female rats, indicating the cytoprotective properties of female sex hormones.

Author Biographies

Illia V Koshurba

KOSHURBA Illia Vasylovych – Doctor of Philosophy (PhD) student in specialty "222 – Medicine" field of knowledge "22 – Health care" in the Department of Experimental Cryomedicine, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 23, Pereyaslavska Str., Kharkiv, 61015, Ukraine; Medical Director for Neonatology, Municipal Non-Profit Enterprise "Chernivtsi Regional Perinatal Center", 1a, Bukovynska Str., Chernivtsi, 58000, Ukraine; Assistant of the Department of Pediatrics, Neonatology and Perinatal Medicine, Bukovynian State Medical University of the Ministry of Health of Ukraine, 2, Theater Sq., Chernivtsi, 58002, Ukraine; tel.: +38 (095) 417-80-06, e-mail: koshurba@gmail.com,

ORCID: https://orcid.org/0000-0002-4595-9245

Scopus: https://www.scopus.com/authid/detail.uri?authorId=57499305600

Web of Science: https://www.webofscience.com/wos/author/record/3335102

Roman R Komorovsky

Komorovsky Roman Rostyslavovych – Doctor of Medical Sciences, Professor, Professor of Internal Medicine Department No 2 of I. Horbachevsky Ternopil National Medical University of the Ministry of Health of Ukraine; 1, Maidan Voli, Ternopil, Ukraine, 46001;

1.1.  e-mail: komorovsky@tdmu.edu.ua

Mykola O Chyzh

Chyzh Mykola Oleksiiovych – Candidate of Medical Sciences, Senior Researcher, act. Head of Experimental Cryomedicine Department of Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine; 23, Pereyaslavska Str., Kharkiv, Ukraine, 61016;

1.1.  e-mail: n.chizh@ukr.net,

Yuri V Koshurba

Koshurba Yurii Vasylovych – Neonatologist, Municipal Non-Profit Enterprise "Chernivtsi Regional Perinatal Center", 1a, Bukovynska Str., Chernivtsi, 58000, Ukraine;

Mykhailo M Marchenko

Marchenko Mykhailo Markovych – doctor of biological sciences, professor, academician of the Academy of Sciences of the Higher School of Ukraine, Honored Worker of Science and Technology of Ukraine, director of the Educational and Scientific Institute of Biology, Chemistry and Bioresources of the Yuri Fedkovich Chernivtsi National University; St. 2, Kotsyubinsky St., Chernivtsi, Ukraine, 58012;

References

Franconi F, Campesi I. Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J of Pharmacol 2014;171(3):580–94.

Freire AC, Basit AW, Choudhary R, Piong CW, Merchant HA. Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery. Int Journ of Pharmaceutics 2011;415(1–2):15–28.

Koshurba IV, Hladkykh FV, Chyzh MO, Belochkina IV, Rubleva TV. Hepatotropic effects of triple antiulcer therapy and placenta cryoextract: the role of sex factors in lipoperoxidation. Fiziol zh 2022;68(5):25–32.

Kolesnikova OV, Radchenko AO, Zaprovalna OE. Gender differences in aging rates among patients with non-alcoholic fatty liver disease. Modern Gastr (Ukraine) 2023;3:5–13.

Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Molecular Pharm 2009;76(2):215–28.

Koshurba IV, Hladkykh FV, Chyzh MO. Modulation of lipid peroxidation and energy metabolism in the gastric mucosa as a mechanism of antiulcer activity of placental cryoextract in the healing of stress-induced ulcers. Gastroenterology 2022;56(3):149–55.

Hladkykh FV, Koshurba IV, Chyzh MO. Characteristics of the antiulcerogenic activity of cryopreserved placenta extract in acute and chronic lesions of the stomach. Modern Med Technol 2023;56(1):62–8.

Pan SY, Chan, MK, Wong MB, Klokol D, Chernykh V. Placental therapy: An insight to their biological and therapeutic properties. Jof Med and Therap 2017;1(3):1–6.

Hladkykh FV. Macroscopic assessment of protective effect of cryopreserved placenta extract in ibuprofen-induced gastroenterocolonopathy. Gastroent 2021;55(3):172–9.

Hladkykh FV. Anti-inflammatory properties of diclofenac sodium on background of its combined use with cryopreserved placenta extract in experiment. Probl Cryobiol Cryomedicine 2021;31(4):364–7.

Hladkykh FV, Chyzh MO. Characteristics of the mechanisms of anti-inflammatory action of cryopreserved placenta extract and diclofenac sodium by their threaded administration. Modern Med Technol 2021;3(50):41–7.

Vogel HG, ed. Drug discovery and evaluation: pharmacological assays: Berlin, Heidelberg: Springer Berlin Heidelberg 2008; p. 2071.

Stefanov ОV. Preclinical studies of drugs: guidelines. Kyiv: Avicenna 2001; p. 527.

Podhirny VV. Hepatotoxic manifestations of lansoprazole, metronidazole and clarithromycin in the experiment. Med Chem 2007;9(2):74–7.

Koshurba IV, Chyzh МO, Hladkykh FV. Influence of placenta cryoextract on the liver metabolic and functional state in case of D-galactosamine hepatitis. Innov Biosyst Bioeng 2022;6(2):64–74.

Rykalo NA. Experimental model of chronic tetrachloromethane hepatitis and liver cirrhosis in immature rats. Actual problems of modern medicine: Bulletin of the Ukrainian Medical Stomatological Academy 2009;9(2):116–8.

Aloisi AM, Ceccarelli I, Fiorenzani P. Gonadectomy affects hormonal and behavioral responses to repetitive nociceptive stimulation in male rats. An NY Acad Sci 2003;1007:232-7.

Joshi SA, Shaikh S, Ranpura S, Khole VV. Postnatal development and testosterone dependence of a rat epididymal protein identified by neonatal tolerization. Reproduction 2003;125(4):3495–507.

Ali BH, Ben Ismail TH, Basir AA. Sex difference in the suspectibility of rats to gentamicin nephrotoxicity: influence of gonadectomy and hormonal replacement therapy. Indian J Pharmacol 2001;33:369–73.

Koshurba IV, Chyzh, MO, Hladkykh FV, Komorovsky RR, Marchenko МM. Role of cryopreserved placenta extract in prevention and treatment of paracetamol-induced hepatotoxicity in rats. Scr Med 2023;54(2):133–9.

Chyzh MO, Koshurba IV, Marchenko MM, Hladkykh FV, Belochkina IV. Gender determinism of the effect of placenta cryoextract on the hepatotropic effects of esomeprazole, clarithromycin and metronidazole in chronic liver damage. Modern Med Technol 2023;56(1):55–61.

Koshurba IV, Hladkykh FV, Chyzh MO. The influence of hormonal status on the hepatotropic effect of esomeprazole, clarithromycin and metronidazole in chronic liver damage and the administration of placenta cryoextract. Gastroenterology 2023;57(2):78–84.

Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphate with five cubic millimeters of serum. J Biol Chem 1946;164:321–9.

Kamyshnikov VS. Handbook of clinical and biochemical research and laboratory diagnostics. Minsk: Interpresservis 2009; p. 896.

Zar JH. Biostatistical analysis (5 ed). Prentice-Hall, Englewood 2014; p. 960.

Chung JW, Choi HY, Ki M, Jang ES, Jeong SH. Comorbidities and prescribed medications in Korean patients with chronic hepatitis c: a nationwide, population-based study. Gut Liver 2021;15(2):295–306.

Kim DJ, Kim HY, Kim SJ, Hahn TH, Jang MK, Baik GH, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med 2008 Mar;23(1):16-21.

Saboo K, Shamsaddini A, Iyer MV, Hu C, Fagan A, Gavis EA, et al. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy. J Hepatol 2021;74(1):80–8.

Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010;16(19):2323–30.

Malfertheiner P, Megraud F, Morain CA, Gisbert JP, Kuipers EJ, Axon AТ, et al; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017 Jan;66(1):6-30.

Koshurba IV, Hladkykh FV, Chyzh MO. Modern approaches to the treatment of peptic ulcer disease and prospects for the use of biological therapy. Modern Med Technol 2023;2(57):58–66.

Hladkykh FV, Kulinich НV, Zolotarova TG. New approaches to radio- and chemosensitization using proton pump inhibitors through the lens of tumor cell microenvironment patterns. UJRO 2023;31(2):230–42.

Kancherla D, Gajendran M, Vallabhaneni P, Vipperla K. Metronidazole induced liver injury: a rare immune mediated drug reaction. Case Rep Gastrointest Med 2013;2013:568193. doi: 10.1155/2013/568193.

Zeng Y, Dai Y, Zhou Z, Yu X, Shi D. Hepatotoxicity-related adverse effects of proton pump inhibitors: a cross-sectional study of signal mining and analysis of the FDA Adverse Event Report System Database. Front Med (Lausanne) 2021 Nov 15;8:648164. doi: 10.3389/fmed.2021.648164.

Pentyuk NO. The effect of hyperhomocysteinemia on the formation of CCl4-induced liver fibrosis in rats. Modern Gastr (Ukraine) 2009;5(46):33–7.

Voronina AK, Borshchevskii GI. Hepatoprotective efficacy drug Lesfal for experimental hepatitis in rats. Pharmacol Med Toxicol 2013;2(33):37–41.

Published
2023/12/21
Section
Original article